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Abstract 
Glimepiride is a novel sulfonylurea for the treatment of type II-diabetic patients exhibiting different receptor binding kinetics 
to B-cell membranes with 8-9-fold higher kof rate and 2.5-3-fold higher kon rate compared to glibenclamide (see accompanying 
paper (Miiller, G. et al. (1994) Biochim. Biophys. Acta 1191, 267-277)). To elucidate the molecular basis for this differential 
behaviour of glimepiride and glibenclamide, direct photoaffinity labeling studies using fl-cell tumor membranes were performed. 
[3H]Glimepiride was specifically incorporated into a membrane polypeptide of M r = 65000 under conditions, which led to 
predominant labeling of a 140 kDa protein by [3H]glibenclamide (Kramer, W. et al. (1988) FEBS Lett. 229, 355-359). Labeling of 
the 140 kDa protein by [3H]glibenclamide was inhibited by unlabeled glimepiride and, vice versa, glibenclamide inhibited 
labeling of the 65 kDa protein by [3H]glimepiride. The 65 kDa protein was also specifically photolabeled by the sulfonylurea 
[1251135623, whereas an 4-azidobenzoyl derivative of glibenclamide, N3-[aH]33055, exclusively labeled a 33 kDa protein. 
Competitive Scatchard analysis of [3H]glimepiride-binding and [3H]glibenclamide-binding to RINm5F cell membranes using 
glibenclamide and glimepiride, respectively, as heterologous displacing compounds yielded non-linear plots. These findings may 
be explained by cooperative interactions between the 140 and 65 kDa sulfonylurea-binding proteins. The possibility that 
sulfonylureas of different structure have different access to the 140 and 65 kDa receptor proteins due to the fl-cell membrane 
barrier was investigated by photoaffinity labeling of solubilized E-cell membrane proteins. Interestingly, solubilization of E-cell 
tumor membranes led to a shift of specific [3H]glibenclamide binding from the 140 kDa to the 65 kDa binding protein, 
exclusively, and to an increased labeling of the 65 kDa protein by [3H]glimepiride. The labeling of a unique protein is in 
agreement with similar K d values measured for both sulfonylureas upon solubilization of /3-cell tumor and RINm5F cell 
membranes (see accompanying paper). Furthermore, competitive Scatchard plots of [3H]glimepiride binding to solubilized 
RINm5F cell membrane proteins in the presence of glibenclamide and vice versa approximate linearity suggesting loss of 
cooperativity between the 140 kDa glibenclamide-binding and 65 kDa glimepiride-binding proteins upon solubilization. The 
physiological significance of the differential interaction of glimepiride and glibenclamide with different binding proteins was also 
substantiated by photoaffinity labeling of RINm5F cells leading to labeling of a 140 kDa protein by [3H]glibenclamide and of a 
65 kDa protein by [3H]glimepiride. In conclusion, this report presents the first evidence that different sulfonylurea drugs bind to 
different components of the sulfonylurea receptor complex which are characterized by different accessibility for the drugs. 
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1. Introduction 
Using direct photoaffinity labeling of fl-cell tumor 
membranes (Kramer et al. [1]), H IT  T15 cell mem- 
branes (Aguilar-Bryan et al. [2,3]) and R INm5F cell 
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membranes (De Weille et al. [4]) with 3H- or 125I- 
labeled glibenclamide analogues, the high-affinity sul- 
fonylurea binding site has been attributed to a 140 kDa 
membrane protein (for a recent review, see Ashcroft 
and Ashcroft [5]). The relative ability of various sul- 
fonylureas to displace [3H]glibenclamide from /3-cell 
membranes parallels their ability to block ATP-regu- 
lated K+-channels, to stimulate insulin release and to 
cause reduction of the blood sugar [6-8]. Whether the 
140 kDa glibenclamide receptor protein is itself (part 
of) the ATP-regulated K+-channel or whether it is a 
separate (transiently or permanently) channel-associ- 
ated protein, has not yet been established. 
So far, no reports are available concerning the char- 
acterization of binding protein(s) for sulfonylureas of 
different structure. Since the novel sulfonylurea, 
glimepiride (Geisen [9]), exhibits a significantly higher 
exchange rate with the sulfonylurea receptor but a 
2.5-3-fold lower binding affinity compared to gliben- 
clamide, we investigated in the present study the 
molecular interaction of glimepiride with the sulfony- 
lurea receptor by direct photoaffinity labeling with 
[3H]glimepiride. In addition to [3H]glimepiride and 
[3H]glibenclamide, two additional photolabile sulfony- 
lureas, N3-[3H]33055 and [125I]35623 were used to 
identify putative protein components of the sulfonyl- 
urea receptor of the pancreatic #-cell. 
Parts of the results have been published in abstract 
form: 
Kramer, W., Okonomopulos, R., Piinter, J. and Summ, 
H.-D. (1992) Diabetologia 35 (Suppl. 1), A 38; 
Miiller, G., Hartz, D., Planter, J., Okonomopulos, R., 
Summ, H.-D. and Kramer, W. (1993) International 
Conference on ATP-sensitive K+-channels and 
sulfonylurea receptors, Houston, TX, Book of Ab- 
stracts, p. 158. 
2. Materials and methods 
Materials. [3H]Glimepiride (65 Ci/mmol), [3H]gli- 
benclamide 33 Ci/mmol), 4-N3-[3,5-3H]33055 (50.8 
Ci/mmol) and [1251135623 (72.4 Ci/mmol) were syn- 
thesized at Hoechst AG, Frankfurt, Germany. 4-N 3- 
[3,5-3H]33055 was synthesized by reaction of N-[4-(fl- 
2-aminobenzamidoethyl)benzenesulfonyl]-N'-cyclohex- 
ylurea with 4-azido[3,5-3H]benzoic acid N-hydroxy- 
succinimide ester (50.8 Ci/mmol) according to the 
procedure described previously (Kramer [10]). Biolute 
S was bought from Zinsser Analytik, Frankfurt, Ger- 
many. Chemicals for electrophoresis were provided 
from Serva, Heidelberg, Germany. Molecular mass 
marker proteins for electrophoresis were obtained from 
Sigma, Deisenhofen, Germany. All other reagents and 
materials were purchased as described in the accompa- 
nying report [11]. Rats of the strain NEDH (New 
England Deaconess Hospital) were kindly donated by 
S. Warren. 
Photoaffinity labeling. For photoaffinity labeling of 
albumin with [3H]glimepiride or [3H]glibenclamide, so- 
lutions of human serum albumin (1 mg/ml) in 100 mM 
sodium phosphate buffer (pH 7.4) were incubated (60 
min, 20°C) with 0.25 /zM [3H]glimepiride or 0.25 ~M 
[3H]glibenclamide in the dark. Irradiation was per- 
formed in a Rayonet RPR-100 photochemical reactor 
(Southern Ultraviolet, Hamden, CT, USA), equipped 
with 16 RPR-2530 or RPR-3000 ,~ lamps at a distance 
of 10 cm from the lamps (according to data of the 
manufacturer, the RPR-2530 ,~ lamps emit 84% of 
their radiation at 2530 ,~, with an intensity of 12800 
/.£W//com2 and 1.65.1016 photons/s per cm3; the RPR- 
3000 A lamps have an emission maximum at 3000 ,~ 
with a half-bandwidth of 30 nm and a photon intensity 
of 4.1017 photons/s per cm3). After definite times 
aliquots were removed, adjusted to 200 /xl with H20 
and protein was precipitated as published [12]. 
For photoaffinity labeling of/3-cell membranes and 
solubilized /3-cell membrane proteins, the 75 000 x g 
pellet, obtained uring preparation of the/3-cell tumor 
membranes, was suspended in 100 mM sodium phos- 
phate buffer (pH 7.4). For labeling of solubilized #-cell 
membrane proteins, CHAPS or Triton X-100 was 
added (final concn. 1% w/v). After incubation (60 min, 
4°C), the supernatant obtained after centrifugation 
(48 000 x g, 30 min) was used for photoaffinity label- 
ing. For this, 600 /zg of /3-cell membrane protein 
(membranes or solubilized membrane proteins) was 
incubated (60 min, 20°C) in a total volume of 200 /xl 
with 25-60 nM (0.3-0.4 /zCi) [3H]glimepiride, 
[3H]glibenclamide, N3-[3H]33055 or [125I]35623 in the 
dark. After irradiation at 254 or 300 nm for 2 min 
([3H]glimepiride, [3H]glibenclamide, [125I]35623) or for 
30 s (N3-[3H]33055) in the photochemical reactor de- 
scribed above, the samples were diluted with 1 ml of 10 
mM Tris-Hepes buffer (pH 7.4), 4 mM EDTA, 4 mM 
iodoacetamide, 4 mM PMSF, centrifuged (48 000 x g, 
30 rain) and protein was precipitated as above. For 
photoaffinity labeling with monochromatic light, the 
samples were irradiated with narrow-bandwidth light 
for 10 min in a rectangular cuvette (1 x 0.1 cm) of 
quartz glass in a sample chamber of a Hitachi F-3000 
fluorimeter (Hitachi, Tokyo, Japan) equipped with a 
150 W xenon arc lamp. Wavelengths were selected with 
the excitation monochromator. After irradiation, 100-tzl 
aliquots (40 /zg) were removed and protein was pre- 
cipitated with 500 tzl of dioxane. 
For photoaffinity labeling of RINm5F cells, (0.5-1)- 
10 6 cells were incubated (10 min, 20°C) with 25 nM 
[3H]glimepiride (0.5 /xCi) or [3H]glibenclamide (0.5 
/~Ci) in the dark and subsequently irradiated at 254 nM 
for 2 min. The cells were then washed twice with 1 ml 
of 10 mM sodium phosphate buffer (pH 7.4), 4 mM 
280 W. Kramer et al. / Biochimica et Biophysica Acta 1191 (1994) 278-290 
PMSF, 4 mM EDTA, 4 mM iodoacetamide. After 
centrifugation (48000 × g, 60 min), the pellets were 
resuspended in 100/xl H20 and proteins were precipi- 
tated and analyzed by SDS-PAGE. 
SDS-PAGE. The dried protein precipitates were dis- 
solved in 70 /~1 of 62.5 mM Tris-HCl (pH 6.8), 2% 
SDS, 5% 2-mercaptoethanol, 0.005% Bromophenol 
blue by shaking on a mixer for 60 min. After centrif- 
ugation (15000 ×g, 10 min), the supernatants were 
submitted to SDS-PAGE on 150 × 180 × 1.5 mm slab 
gels as described (Kramer et al. [13,14]). After fixing 
and staining, the gels were scanned with a CD-50 
densitometer, Desaga, Heidelberg, Germany and then 
scanned for radioactivity by liquid scintillation counting 
of 2-mm gel pieces after digestion of proteins with 
Biolute S. 
Miscellaneous. Culture of RINm5F ceils, preparation 
of /3-cell tumor membranes and RINm5F cell mem- 
branes and Scatchard plot analysis of specific 
[3H]glimepiride and [3H]glibenclamide binding to 
RINm5F cell membranes or solubilized RINm5F cell 
membrane proteins using rapid filtration and precipita- 
tion with poly(ethylene glycol) were performed as de- 
scribed in the accompanying report [11]. 
3. Results 
3.1. Competitive Scatchard plotanalysis of [ 3H]glimepi- 
ride and [ 3H]glibenclamide binding 
Competitive Scatchard plot analysis (Fig. 1) of 
[3H]glimepiride (Panel A) and [3H]glibenclamide 
(Panel B) equilibrium binding to RINm5F cell mem- 
branes in the presence of varying concentrations of
unlabeled glibenclamide (Glib.) and glimepiride 
(Glim.), respectively, resulted in non-linear concavely 
shaped plots, which could not be attributed to distinct 
high- and low-affinity binding sites (Panel A, Glib.; 
Panel B, Glim.). The non-competitive type of binding 
inhibition observed for this heterologous Scatchard 
analysis markedly differs from the corresponding ho- 
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Fig. L Competitive Scatchard plot analysis of specific [3H]glimepiride 
or [3H]glibenclamide binding. 200 txg of RINm5F cell membranes 
were incubated (60 min, 20 °) with 0.5 nM [3H]glimepiride (Panel A) 
or [3H]glibenclamide (Panel B) in the presence of 0.1-100 nM 
unlabeled glimepiride (+)  or glibenclamide (D)  and then rapidly 
filtered. Specific glimepiride-binding and glibenclamide-binding was 
determined and the means of at least 16 independent determinations 
obtained with four different membrane preparations were used for 
the Scatchard plot analysis. 
mologous analysis (i.e., [3H]glibenclamide and 
[3H]glimepiride binding in the presence of unlabeled 
glibenclamide and glimepiride, respectively) (see for a 
comparison Fig. 1 of the accompanying paper). These 
findings together with the different binding parameters 
(K d, kon, kof values) of the glimepiride and gliben- 
clamide high-affinity binding sites (see Table 1 of the 
Table 1 
Effect of UV irradiation on viability of RINm5F ~ells 
Time (min) % Trypan blue-stained RINm5F cells 
0 0.5 1 2 5 10 15 20 30 
Wavelength 
254 nm 2 4 3 5 6 5 7 10 12 
300 nm 4 5 4 7 8 7 9 12 15 
control 3 3 4 4 5 4 6 8 7 
RINm5F cells (0.75 • 106 cells/ml) were incubated at 25°C in a Rayonet RPR-100 photochemical reactor at a distance of 10 cm from either 16 
RPR-100 2530 .~ or 16 RPR-3000 A lamps or were incubated without irradiation (control). After various periods 150/xl aliquots were removed 
and supplemented with 50/zl  Trypan blue solution (0.1%). The number of stained cells was determined under the phase contrast microscope 
within 2 min. The values calculated as % stained cells for each of the three incubation conditions are derived from one typical experiment 
repeated three times. 
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accompanying paper [11]) represent first hints to the 
existence of distinct binding sites of the two drugs in 
0-cell membranes (for a discussion of Scatchard plot 
and heterogeneity in binding affinity of labeled and 
unlabeled ligand see Refs. [15-18]. 
3.2. Different proteins of O-cell tumor membranes are 
photoaffinity labeled by [ 3H]glimepiride and [ 3H]gliben- 
clamide 
To obtain information for the above hypothesis at a 
molecular level, we performed photoaffinity labeling 
studies with O-cell tumor membranes using four differ- 
ent photoaffinity probes, [3H]glimepiride, [3H]gliben- 
clamide, a 4-azido-[3,5-3H]benzoyl derivative of gliben- 
clamide, N3-[aH]33055, and [1251135623 (Fig. 2). The 
suitability of [3H]glibenclamide as a direct photo- 
affinity probe upon irradiation with UV-light at 254 nm 
or 300 nm has been demonstrated previously (Kramer 
et al. [1]) and aromatic azido-compounds are well es- 
tablished as nitrene-generating photoaffinity probes 
(Bayley [19]). Owing to the a,0-unsaturated carbonyl 
function in the molecule, a photocatalyzed activation 
of glimepiride via a n-zr* transition state seemed 
possible (Martyr and Benisek [20]). Therefore, at first 
the ability of [3H]glimepiride to act as a direct photo- 
affinity probe was investigated by irradiation of human 
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CI 
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Fig. 2. Chemical structure of [3H]glimepiride, [3H]glibenclamide, 
N3-[3H]33055 and [1251135623. 
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Fig. 3. Photocatalyzed incorporation of [3H]glimepiridc into human 
serum albumin. Human serum albumin (1 mg/ml) in 100 mM 
sodium phosphate buffer (pH 7.4) was incubated (10 min, 20°C) with 
0.25 /zM [3H]glimepiride (8 ~Ci/mg protein) in the dark. Photo- 
affinity labeling was carried out at various wavelengths between 220 
and 300 nm. After 3 min irradiation, aliquots containing 40 /zg 
protein were removed and protein was precipitated. The covalent 
attachment of [3H]sulfonylareas to albumin was determined by scin- 
tillation counting after SDS-PAGE and slicing of the gels. 
albumin solution in the presence of [3H]glimepiride 
with monochromatic light of different wavelength. Fig. 
3 shows that photocatalyzed incorporation of 
[3H]glimepiride into protein was achieved in the range 
of 220-300 nm with a maximum at 280 nm (upper 
panel). [3H]Glibenclamide showed a nearly identical 
wavelength dependence for photoincorporation (lower 
panel). Thus, photoaffinity labeling experiments with 
0-cell membranes were carried out in a photochemical 
reactor RPR-100 equipped with 16 RPR-2530 ~ lamps 
having their maximum of light emission at 254 nm. 
(Identical results were obtained using RPR-3000 .~ 
lamps which have their maximum of emission at 300 
nm). Photolabeling with [3H]-glimepiride, [3H]- 
glibenclamide and [1251135623 was carried out for 2 min 
at 254 nm, whereas 30 s at 254 nm was applied for 
N3-[3H]33055, the half-life time under these conditions 
being 3.5 s (Kramer et al. [10]). After photoaffinity 
labeling of 0-cell membranes, the membranes were 
washed and polypeptides were separated by SDS- 
PAGE followed by determination of radioactively la- 
beled polypeptides after slicing of the gels into 2-ram 
pieces. 
[3H]Glibenclamide was predominantly incorporated 
into two membrane polypeptides with apparent M r of 
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Fig. 4. Photoaffinity labeling of fl-cell tumor membranes with 
[3H]glimepiride. /3-cell tumor membranes (600 Izg protein) were 
incubated (60 min, 20°C) in the dark with 30.76 nM [3H]glimepiride 
(0.5 /~Ci) and subsequently irradiated at 254 nm for 2 min. After 
washing of the membranes, proteins were separated by SDS-PAGE. 
The continuous line shows the distribution of Serva-blue R-250 
stained polypeptides, the broken line denotes thedistribution of 3H 
radioactivity as determined by liquid scintillation counting of the 
sliced gels. Molecular masses (in kDa; at top of the figure) of the 
marker proteins are indicated by arrows. 
140000 and 33000 (Kramer et al. [1]). In contrast, 
photoaffinity labeling with [3H]glimepiride led to cova- 
lent modification predominantly of one polypeptide 
with an apparent M r of  65 000, whereas no significant 
labeling of the 140 kDa polypeptide could be detected 
(Fig. 4). With the nitrene-generating N3-[3H]33055 a 
nearly exclusive labeling of only one polypeptide of 
M r = 33000 occurred (Fig. 5, upper panel). Direct 
photoaffinity labeling with [1251135623 led to an exclu- 
sive incorporation of the photoprobe into one polypep- 
tide of M r = 65 000, as shown by autoradiography after 
SDS-PAGE (Fig. 6). The labeling of different binding 
proteins for [3H]glimepiride, [3H]glibenclamide, N 3- 
[3H]33055 and [1251135623 may reflect different binding 
affinities of sulfonylureas to one or the other binding 
site, which determines uccess or failure of photocross- 
linking. The concentrations of the photoprobes in the 
labeling experiments were in the range of 25-60 nM. 
Qualitatively, the same labeling pattern was obtained 
using the probes in the concentration range of 1-10 
nM, but the incorporation yields were rather low. In 
further control experiments, no differences in the la- 
beling patterns of a distinct sulfonylurea photoprobe 
was found up to concentrations of  100 nM. 
In order to elucidate whether the binding proteins 
for glibenclamide and glimepiride identified in fl-cell 
membranes are also physiologically involved in binding 
of sulfonylureas, we performed photoaffinity labeling 
studies with R INm5F cells using [3H]glibenclamide 
and [3H]glimepiride. Since the wavelength necessary 
for photocrosslinking of these ligands may damage 
living cells, we measured in a first series of experiments 
the influence of irradiation on cell viability. Irradiation 
8 
6 
4 
z, 
8 
6 
Mr- 10 .3 
205 11697 66 ~3 36 29 24 
v v y y Y V33VV 
y 
m 
_+ 10 .4 M glibenelamide f~l 
I I 
+ 10-4 M tolbutamide 
- -  91  
t 
t 
I 
I 
L I 
1 I I I I 
2 4 6 B 10 
MIGRATION (em) 
Fig. 5. Photoaffinity labeling of fl-cell tumor membranes with N 3- 
[3Hl33055./~-cell tumor membranes (500/~g protein) were incubated 
(15 min, 20°C) and subsequently (5 min, 0°C) with 51 nM N 3- 
[3H]33055 (0.65 ~Ci) in 100 mM sodium phosphate buffer (pH 7.4) 
either in the absence (upper panel) or presence of 10 _4 M gliben- 
clamide (middle panel) or 10 4 M tolbutamide (lower panel). After
photolabeling at 254 nm for 30 s and washing of the membranes, 
proteins were separated by SDS- PAGE. The continous line shows 
the distribution f Serva-blue R-250 stained polypeptides, the broken 
line the distribution of radioactivity. 
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97 
bated for 10 min in the dark either with [3H]glimepiride 
or [3H]glibenclamide and subsequently irradiated at 
254 nm for 2 min. After washing, cells were disrupted 
by osmotic shock and particulate material was col- 
lected by centrifugation. Fig. 7 shows that irradiation in 
the presence of [3H]glibenclamide led to an incorpora- 
tion of radioactivity into a 140 kDa protein (lower 
panel), whereas with [3H]glimepiride a 65 kDa protein 
was labeled (upper panel). Therefore, also in intact 
/3-cells, glimepiride and glibenclamide have access to 
different binding proteins which according to their 
..... , ~ < h~: ¸  ~,, ; 
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Fig. 6. Photoaffinity labeling of 0-cell tumor membranes with 
[125I]35623. 0-ceU tumor membranes (500 p.g protein) were incu- 
bated (15 min, 20°C) with 27.6 nM [1251135623 (0.4/zCi) in the dark 
and subsequently irradiated at 254 nm for 2 min. After washing of 
the membranes, proteins were separated by SDS-PAGE. An auto- 
radiography of the dried gel is shown. The molecular masses indi- 
cated were derived from marker proteins run in parallel on the same 
gel. 
of RINm5F cells (10.75.10 6 cells/ml) was performed 
in a Rayonet RPR-100 photochemical reactor at a 
distance of 10 cm from the lamps using either 16 
RPR-2530 .~ or 16 RPR-3000 ,~ lamps with subsequent 
determination of cell viability by Trypan blue exclu- 
sion. Table 1 shows that within the irradiation times 
necessary for sufficient photoaffinity labeling with 
[3H]glimepiride and [3H]glibenclamide both at 254 nm 
and 300 nm, no significant impairment of RINrn5F cell 
viability compared to control ceils occurred. Conse- 
quently, RINm5F cells (1.10 6 cells/ml) were incu- 
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Fig. 7. Photoaffinity labeling of RINm5F cells with [3H]glimepiride 
and [3H]glibenclamide RINm5F cells (1'106 cells/ml) were incu- 
bated (10 min, 20°C) with 25.6 nM [3H]glimepiride (0.5/zCi) or 25.4 
nM [3H]glibenclamide (0.5/~Ci) in the dark and subsequently irradi- 
ated at 254 nm for 2 min. After washing, the particulate material was 
collected by centrifugation, suspended, precipitated and finally pro- 
teins were separated by SDS-PAGE. The distribution of 3H radioac- 
tivity as determined by liquid scintillation counting of the sliced gels. 
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Fig. 8. Competitive photoaffinity labeling of the140 kDa protein by 
glimepiride, glibenclamide and tolbutamide, fl-cell tumor mem- 
branes (600 tzg protein) were incubated (60 min, 20°C) inthe dark in 
the presence of various concentrations (10 -8 to 10 -4 M) of 
glimepiride, glibenclamide or tolbutamide. After incubation (10 min, 
20°C) with 60 nM [3H]glibenclamide (0.37 /xCi) in the dark, the 
membranes were irradiated at 254 nm for 2 rain. After washing of 
the membranes, the proteins were separated by SDS-PAGE and 
counted for radioactivity by liquid scintillation counting of the sliced 
gels (shown only for glimepiride in Panel A). The logarithmic plots of 
the drug concentration used for the competition versus the 3H-radio- 
label bound to the 140 kDa protein are shown in Panel B. The ICs0 
values for half-maximal inhibition of [3H]glimepiride binding are 
indicated by arrows. 
apparent M r may be related to the corresponding 
binding proteins in the fl-cell tumor membrane. 
The specificity of the photolabeled sulfonylurea- 
binding proteins was corroborated by competitive 
photoaffinity labeling with [3H]glimepiride, [3H]gliben- 
clamide or Na-[aH]33055 in the presence of excess of 
unlabeled sulfonylureas. Photoaffinity labeling of fl-cell 
membranes with [3H]glibenclamide in the presence of 
increasing concentrations of unlabeled glimepiride led 
to a concentrat ion-dependent d crease in the labeling 
of the 140 kDa protein (Fig. 8, Panel A). Blotting of 
radioactivity incorporated into the 140 kDa protein 
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Fig. 9. Competitive photoaffinity labeling of the 65 kDa protein by 
glibenclamide and tolbutamide, fl-ce]] tumor membranes (500/~g 
protein) were incubated (60 rain, 20°C) in the dark in the absence 
(upper panel) or presence of 10 -4 M glibenclamide (middle panel) 
or 10 -4 M tolbutamide (lower panel). After incubation (10 rain, 
20°C) w th 30.76 nM [3H]glimepiride (0.5 ~Ci) in the dark, the 
membranes were irradiated at 254 nm for 2 rain. After washing of 
the m mbranes, proteins were separated by SDS-PAGE and counted 
for radioactivity by liquid scintillation counting of the sliced gels. 
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against the concentration of the respective sulfonyl- 
ureas (Panel B) revealed an IC50 value of 10 -8 M for 
half-maximal inhibition of photolabeling by glimepiride. 
Glibenclamide showed an ICs0 value of 3 .10  -8 M, 
whereas for tolbutamide, as expected, much higher 
concentrations were required (IC50-- 6.5" 10 -5 M). 
Analogous experiments for the 65 kDa protein re- 
vealed that its labeling by [3H]glimepiride was also 
concentration-dependently i hibited by other sulfonyl- 
ureas (Fig. 9). The concentrations of sulfonylurea nec- 
essary for inhibition, however, were significantly higher 
than for the 140 kDa protein. Similar results were 
obtained using [1251135623 as photoprobe for labeling 
the 65 kDa protein (data not shown). The intensive 
labeling of the 33 kDa polypeptide by N3-[3H]33055 
was not inhibited by unlabeled sulfonylureas like 
glibenclamide or tolbutamide to a significant extent 
(Fig. 5, middle and lower panels). (The labeling of the 
33 kDa polypeptide by Na-[3H]33055, however, was 
'specific' in the sense that photolabeling with 4-azido- 
[3,5-3H]benzoic acid N-hydroxysuccinimide ester, a 
precursor in the synthetic procedure, led to unspecific 
labeling of a variety of membrane proteins; data not 
shown). 
3.3. Effect o f  solubilization on photoaffinity labeling of  
the glimepiride-binding and glibenclamide-binding pro- 
teins 
Since on the one hand glimepiride inhibited labeling 
of the 140 kDa protein by [3H]glibenclamide without 
an obvious direct binding to the 140 kDa protein and 
on the other hand glibenclamide inhibited labeling of 
the 65 kDa protein by [3H]glimepiride, it seemed possi- 
ble that both proteins are subunit constituents of the 
sulfonylurea receptor complex interacting with each 
other in a cooperative manner. Sulfonylureas of differ- 
ent structure may have different access to these pro- 
teins embedded in the/3-cell plasma membrane. Con- 
sequently, we examined whether photoaffinity labeling 
of the respective proteins is dependent on the intact 
structure of the membrane or resists solubilization by 
detergent. 
Fig. 10, Panel A shows that photoaffinity labeling of 
the 65 kDa protein by [3H]glimepiride was greatly 
increased by solubilization of the membranes with Tri- 
ton X-100 (upper diagram) or other non-ionic deter- 
gents such as octyl glucoside or CHAPS (data not 
shown) prior to UV-irradiation compared to the intact 
Triton-solubilized 
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Fig. 10. Photoaffinity labeling of solubilized /3-cell membrane proteins with [3H]glimepiride (Panel A) and [3H]glibenclamide (Panel B). /3-cell 
tumor membranes and solubilized g-cell tumor membrane proteins (Panel A: 1% TX-100; Panel B: 1% CHAPS) (600 /zg protein) were 
incubated (60 min, 20°C) with 30.76 nM [3H]glimepiride (0.5 gCi) (Panel A) or 48.3 nM [3H]g!ibenclamide (0.3 ~Ci) (Panel B) in the dark and 
subsequently irradiated at 254 nm for 2 min. After washing of the membranes, proteins were separated by SDS-PAGE. The distribution f 3H 
radioactivity along the gel was determined by liquid scintillation counting of the sliced gels. The molecular weights (at top of the figure) are  
indicated by arrows. 
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membrane (lower diagram), and no additional proteins 
were radiolabeled. This indicates either an increased 
access of glimepiride to the 65 kDa protein or a 
tremendous increase of affinity of the 65 kDa protein 
for glimepiride upon solubilization. Similar experi- 
ments with [3H]glibenclamide asa photoprobe showed 
(Panel B) that the 140 kDa protein, predominantly 
labeled in /3-cell membranes (upper diagram), was no 
longer labeled by [3H]glibenclamide after solubilization 
of the membrane with nonionic detergents (lower dia- 
gram). Instead a nearly exclusive incorporation of 
[3H]glibenclamide into the 65 kDa protein occurred 
indicating a shift of glibenclamide binding from the 140 
kDa protein to the 65 kDa binding protein. Competi- 
tive photolabeling experiments using structurally differ- 
ent ligands revealed that the solubilized 65 kDa bind- 
ing protein has similar binding specificity as the 140 
kDa binding protein (data not shown). 
Upon solubilization of RINm5F cell membranes, 
the non-linear concavely shaped curve of the competi- 
tive Scatchard plots (i.e., [3H]glimepiride binding in 
the presence of unlabeled glibenclamide and 
[3H]glibenclamide binding in the presence of unlabeled 
glimepiride; see Fig. 1) were converted to a linear 
component of the high-affinity binding site (Fig. 11, 
Panel A, Glib. and Panel B, Glim., respectively). The 
analogous effect of solubilization was also observed for 
Scatchard plot analysis of [3H]glibenclamide binding in 
the presence of unlabeled iodo-35623 (Fig. 12, Panel B, 
compare membr, and solub.). This suggests either the 
disappearance of low/medium affinity binding sites, 
which could not be resolved from the high-affinity 
binding sites when embedded within the membrane, or 
the disruption of the (negative) cooperative interaction 
between the glimepiride-binding and glibenclamide- 
binding sites. In contrast o the Scatchard analysis of 
[3H]glimepiride binding to RINm5F cell membranes in
the presence of glibenclamide and vice versa (Fig. 1), 
[3H]glimepiride binding to RINm5F cell membranes in
the presence of unlabeled iodo-35623 resulted in linear 
Scatchard plots (Fig. 12, Panel A, membr.). Thus, solu- 
bilization of the membranes i  not required to observe 
competitive binding inhibition between these two drugs 
and, in fact, did not affect the linearity of the Scatchard 
plot (Panel A, solub.). Since glimepiride and iodo-35623 
presumably bind to the same 65 kDa binding protein, 
the non-linearity of the Scatchard plots and, thus, the 
non-competitive nature of binding of glimepiride and 
glibenclamide to RINm5F cell membranes, eems to 
rely on binding to different receptor proteins (65 and 
140 kDa, respectively) which interact with one another 
in an allosteric fashion. Solubilization of the /3-cell 
membrane presumably causes dissociation of the puta- 
tive sulfonylurea receptor complex into monomeric 65 
kDa glimepiride-binding and 140 kDa glibenclamide- 
binding proteins. This might explain the shift from 
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Fig. I 1. Competitive Scatchard plot analysis of [3 H]glimepiride (Panel 
A) and [3H]glibenclamide (Panel B) binding to solubilized RINm5F 
cell membrane proteins by glimepiride and glibenclamide. The ex- 
periments were carried out as described in the legend to Fig. 1 but 
using 200 /zg of digitonin-solubilized RINm5F cell membrane pro- 
teins and precipitation of the solubilized proteins with poly(ethylene 
glycol) prior to filtration. 
non-competitive to competitive type of inhibition of 
[3H]glimepiride-binding by glibenclamide and vice versa 
in Scatchard plot analysis using heterologous ligands 
[15-17]. The steady-state and kinetic binding experi- 
ments (see accompanying paper [11]) as well as the 
competitive Scatchard analyses and photoaffinity label- 
ing studies using solubilized membranes hint to an 
attenuating effect of the membrane nvironment or of 
the interaction with the glibenclamide binding protein 
on the affinity or accessibility of the glimepiride bind- 
ing protein which can be overcome by solubilization. 
4. Discussion 
A 140 kDa protein in /3-cell tumor membranes has 
been demonstrated previously to be photoaffinity la- 
beled by [3H]glibenclamide with high specificity and 
selectivity (Kramer et al. [1]). With an iodinated ana- 
logue of glibenclamide, 5-iodo-2-hydroxyglibenclamide, 
W. Kramer et al. / Biochimica et Biophysica Acta 1191 (1994) 278-290 287 
0,025 A [3-HlGlimepiride Bound 
0,02 + 
0,016 
+'N,+ membr. 
0,01 S ~  ~+~ 
. o,oo  
- o ~ ~  ÷~ 
te 0 , , , 
0,6 1 1,6 
o.1 ~_ [3-H]Glibenclamide Bound B 
0,08 - 
\ 
m [] 
0,06 
[] solub. 
0,04 
membr.\+. [] 
0,02 
0 
0 0,26 0,5 0,75 1 1,25 
Bound (prnol/mg) 
Fig. 12. Competitive Scatchard plot analysis of [3H]glimepiride (Panel 
A) and [3H]glibenclamide (Panel B) binding by iodo-35623. The 
experiments were carried out as described in the legends to Figs. 1 
and 11 by incubation (60 min, 25°C) of 200 /zg of RINm5F cell 
membranes (+,  membr.) and digitonin-solubilized RINm5F cell 
membrane proteins (D, solub.) in the presence of 1 nM-10 /xM 
unlabeled iodo-35623 and then (after precipitation of the solubilized 
proteins with poly(ethylene glycol)) rapidly filtered. Specific 
glimepiride-binding and glibenclamide-binding was determined and 
the means of at least 10 independent determinations were used for 
Scatchard plot analysis hown in the figure. 
four polypeptides with M r = 65 000, 55 000, 43 000 and 
30000 were additionally labeled in HIT T15 cells [2]. 
Differential photolabeling by various sulfonylureas re- 
vealed half-maximal displacements (and K i values cal- 
culated thereof) for the 30-65 kDa proteins in the low 
micromolar ange. Consequently, these proteins were 
attributed to low-affinity binding sites (Nelson et al. 
[21]). 
Photoaffinity labeling of /3-cell tumor membranes 
with [3H]glimepiride led to an exclusive incorporation 
of the photoprobe into a 65 kDa protein under condi- 
tions where [3H]glibenclamide labeled the 140 kDa 
protein. Since glimepiride was bound by/~-cell tumor 
and RINm5F cell membranes with K a values in the 
low nanomolar ange (see accompanying paper [11]), 
and since labeling of the 65 kDa protein was inhibited 
dose-dependently b glibenclamide and tolbutamide, 
this protein seems to be the high-affinity binding site 
for glimepiride. 
The failure of the 65 kDa protein to become photo- 
labeled by [3H]glibenclamide using ]3-cell membranes 
may have different reasons. 
(i) It may be argued that the photochemistry of the 
2-methoxy-5-chlorobenzene ri g in glibenclamide and 
of the 3-ethyl-4-methyl-3-pyrrolin-2-on ring in glime- 
piride differs completely with respect to addition to 
double bonds and insertion into single bonds at the 
binding site of the sulfonylurea binding protein(s). 
However, since both compounds have a similar struc- 
ture and space-filling and a nearly identical wavelength 
dependence for photoincorporation into albumin 
strongly suggesting a similar photochemical mechanism 
of covalent crosslinking, this explanation is rather un- 
likely. 
(ii) The 65 kDa protein may be an artefact produced 
by photochemically induced proteolysis of the 140 kDa 
protein. This possibility can be excluded based on the 
following findings. (1) During preparation or elec- 
trophoresis of /3-cell membranes labeled with 
[3H]glibenclamide, we never observed the appearance 
of a radiolabeled 65 kDa band and the disappearance 
of the 140 kDa band. (2) Addition of proteinase in- 
hibitors during /3-cell tumor isolation, membrane 
preparation, photolabeling or electrophoresis never led 
to the labeling of the 140 kDa protein by 
[3H]glimepiride. (3) Variation of incubation time, pho- 
tolysis time or irradiation wavelength (254 or 300 nm) 
affected only the incorporation yield but had no influ- 
ence on the labeling pattern. (4) Photoaffinity labeling 
of /3-cell membranes in the frozen state at -196°C 
after incubation of/3-cell membranes with 3H-labeled 
glimepiride or glibenclamide l d to the same labeling 
patterns as described above excluding the possibility of 
proteolysis and photodestruction of the 140 kDa pro- 
tein. 
(iii) The respective receptor protein(s) may be inac- 
cessible for the sulfonylureas from the outer face of the 
membrane. This view is strengthened by the observa- 
tion that disruption of the membrane barrier by solubi- 
lization greatly increased the intensity of photolabeling 
of the 65 kDa protein by [3H]glimepiride which was 
accompanied by a decrease of the K d value for 
glimepiride from 1.46 nM with /3-cell membranes to 
0.55 nM with solubilized /3-cell membrane proteins 
(see accompanying paper [11]). Additionally, the K d 
value for glibenclamide (about 0.5 nM) was not changed 
by solubilization when binding of [3H]glibenclamide 
completely shifted from the 140 kDa protein to the 65 
kDa protein. As in /3-cell membranes, other sulfony- 
lureas were able to displace either [3H]glibenclamide 
or [3H]glimepiride from the solubilized receptor and to 
inhibit photoaffinity labeling of the 65 kDa protein. 
Thus, the capability of the two sulfonylureas to gain 
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access to the 65 kDa and 140 kDa binding polypeptides 
in the fl-cell membrane may rely on the spontaneous 
insertion of the compounds into the phospholipid bi- 
layer. Interestingly, the partitioning behaviour between 
an octanol and water phase varies widely within the 
class of sulfonylurea drugs (Panten et al. [8]). A rapid 
membrane partitioning of glimepiride may prevent its 
photocrosslinking to the 140 kDa glibenclamide bind- 
ing protein if this is amenable to photolabeling only 
from the outer face of the membrane. Alternatively, 
the presence of detergent may simply decrease the 
binding affinity of the 140 kDa and increase the affinity 
of the 65 kDa sulfonylurea receptor. We think this 
possibility less likely since, according to competitive 
photolabeling, the binding selectivity of the 65 kDa 
protein was not altered after solubilization arguing 
against gross conformational changes. 
The photolabeling studies described above and those 
performed by others clearly indicate, that the labeling 
patterns of sulfonylurea-binding proteins greatly de- 
pends on the structure of the sulfonylurea photoprobe 
used. With [3H]glibenclamide, the radiolabeled form of 
the therapeutically used sulfonylurea, only two poly- 
peptides of Mr = 140000 and 33000 were labeled 
(Kramer et al. [11]). Use of 5-iodo-2-hydroxyglyburide, 
where the 2-methoxy-5-chlorobenzene ri g in gliben- 
clamide was substituted by the more bulky and hy- 
drophobic 5-iodo-2-hydroxybenzene ri g, led to label- 
ing of 140 kDa, 65 kDa, 55 kDa and 30 kDa poly- 
peptides with a strong preference for the 140 kDa 
binding protein (Nelson et al. [21]). The sulfonylurea 
[1251135623 containing a 2-hydroxy-5-halobenzene ri g 
of identical photochemical behaviour like gliben- 
clamide or 5-iodo-2-hydroxyglibenclamide (Aquilar- 
Bryan et al. [2]) led to prominent labeling of a 65 kDa 
protein in /3-cell membranes, exclusively, and also in 
intact HIT T15 cells (Niki et al. [22]). Thus, a putative 
different photochemical reactivity of glimepiride and 
glibenclamide cannot account for the binding of 
[3H]glimepiride and [3H]glibenclamide to different 
binding proteins. Interestingly, a new nitrene-gener- 
ating derivative of glibenclamide also predominantly 
labels a 140 kDa protein in /3-cell membranes 
(Schwanstecher t al. [23]). In contrast, the bulkier 
N3-[3H]33055 exclusively labeled the 33 kDa protein. 
The results described here and elsewhere (Nelson et 
al. [21]) exclude the hypothesis that the 140 kDa pro- 
tein is a dimer of glibenclamide-binding subunits of 
M r = 65 000 as suggested by Niki et al. [22]). With the 
exception of the 33 kDa protein, the labeling of the 
sulfonylurea-binding proteins, labeled to different ex- 
tent by the above-mentioned photolabile glibenclamide 
and glimepiride probes, was concentration-dependently 
and specifically inhibited by unlabeled sulfonylureas. 
These findings with /3-cell membranes are reflected by 
photoaffinity labeling studies in intact cells. Whereas 
Table 2 
Label ing of sulfonylurea binding proteins in fl-cell tumor membranes  
by different sulfonylurea photoprobes 
Compounds Photo labeled proteins 
140 kDa 65 kDa 55 kDa 33 kDa 
[3H]Gl ibenclamide + - _ + 
[3H]Gl imepir ide - + - _ 
[ 1251135623 - + - - 
N3-[3H]33055 - _ _ + 
[125 l]5-iodo-2-hydroxy- + ( + ) ( + ) ( + ) 
gl ibenclamide 
glibenclamide labels a 140 kDa protein in RINm5F 
cells, glimepiride is incorporated into a 65 kDa protein. 
Furthermore, [125I]35623 exclusively binds to a 65 kDa 
protein after labeling of HIT T15 cells (Niki et al. [22]). 
From the relationship between structure and photo- 
labeling patterns of different sulfonylureas (Table 2), it 
becomes evident that the photoprobes predominantly 
labeling the 140 kDa protein contain an cyclohexyl- 
amino moiety (glibenclamide, 5-iodo-2-hydroxy- 
glibenclamide), whereas the compounds preferably la- 
beling the 65 kDa protein contain a 4-trans-methyl- 
cyclohexyl amine residue (glimepiride, [125I]35623). This 
structural difference in the sulfonylurea molecule seems 
to determine binding to the 65 or 140 kDa sulfonylurea 
binding proteins, respectively. These data strongly sup- 
port the hypothesis, that the functional sulfonylurea 
receptor within the /3-cell membrane is composed of 
subunits, among them the 140 kDa and 65 kDa pro- 
teins. The hypothesis that the /3-cell sulfonylurea re- 
ceptor consists of a complex built up by several sub- 
units is a matter of controversy at the moment (see 
Ozanne et al. [24] vs. Skeer et al. [25] and Nelson et al. 
[26]). The finding of a functional M r = 134000-166000 
of the sulfonylurea receptor in the native as well as 
solubilized state as determined by target size analysis 
and gel filtration, respectively, (Skeer et al. [25]) is not 
in conflict with our results, since the functional molec- 
ular mass was determined using binding and photo- 
affinity labeling of [3H]glibenclamide. We also ob- 
served a linear Scatchard plot for glibenclamide bind- 
ing and an almost exclusive incorporation of 
[3H]glibenclamide into the 140 kDa protein arguing 
against allosteric interactions between the gliben- 
clamide-binding and glimepiride-binding proteins if 
only one binding site is occupied. Further evidence for 
this interpretation will require radiation inactivation of 
/~-cell membranes followed by competitive Scatchard 
plot analysis of [3H]glibenclamide binding in the pres- 
ence of glimepiride and vice versa or gelfiltration of 
solubilized [3H]glibenclamide-labeled /3-cell mem- 
brane proteins in the presence of glimepiride and vice 
versa. 
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Despi te  the fact that [3H]gl imepir ide and 
[3H]glibenclamide were crosslinked to two distinct pro- 
teins, they competed each other for photolabeling sug- 
gesting a direct interaction of both sulfonylurea bind- 
ing proteins as subunits of a common receptor com- 
plex. According to this hypothesis, occupancy of one 
binding protein decreases the binding affinity of the 
other in a negative cooperative manner. Thus, the two 
sulfonylureas eem to inhibit steady-state binding or 
photoaffinity labeling of each other by allosteric mech- 
anisms rather than by competition for the same binding 
site. This interpretation is substantiated by Scatchard 
plot analysis when [3H]glimepiride was diluted with 
unlabeled glibenclamide and vice versa. However, this 
does not explain the discrepancy between the higher 
potency of glimepiride in inhibiting photolabeling and 
its lower potency in competing equilibrium binding 
compared to glibenclamide. Besides other factors, the 
exchange rate of the ligand with the receptor deter- 
mines the efficiency of photoaffinity labeling and the 
inhibitory effect of competing ligands (Pomerantz et al. 
[27]). In fact, glimepiride binding to/t-cel l  membranes 
is characterized by drastically higher dissociation and 
association rates compared to glibenclamide. The re- 
sulting ~ 3-fold higher exchange rate of glimepiride 
correlates well with the 3-fold lower concentration of 
this drug required for half-maximal inhibition of photo- 
labeling using [3H]glibenclamide. 
The role for the sulfonylurea receptor of the 33 kDa 
protein being also photolabelled by [3H]glibenclamide 
and exclusively by the radiolabeled azidobenzoyl-de- 
rivative of glibenclamide, N3-[3H]33055, remains un- 
clear (see Table 2). Unlabeled N3-33055, however, was 
able to displace [3H]glibenclamide from /3-cell mem- 
branes in a competition binding assay. The concentra- 
tions necessary were about 100-fold higher than those 
for unlabeled glimepiride or glibenclamide (data not 
shown). Attachment of a bulky aromatic residue, such 
as the azidobenzoyl group, to the aromatic benzamido 
radical of the glibenclamide molecule leads to a strong 
decrease in affinity to the sulfonylurea receptor, a 
finding also observed with a fluorescent fluorescein-de- 
rivative of glibenclamide (Miiller, G., unpublished re- 
suits). 
We do not know the physiological relevance of the 
differential photoaffinity labeling of sulfonylureas of 
different structure. Since the identity of the 140 and 65 
kDa components of the putative sulfonylurea receptor 
complex is unknown so far, it remains unclear whether 
one or both of them are constituents of the ATP-de- 
pendent K÷-channel in the/3-cell plasma membrane or 
interact as regulatory proteins with the channel in a 
transient manner. Obviously, occupancy of one compo- 
nent seems to be sufficient for channel inhibition and, 
as a consequence, stimulation of insulin release. Inter- 
estingly, for Ca2÷-channels in various tissues charac- 
terized with different (photo)-affinity probes, similar 
molecular masses of 140-170 kDa, 52-60 kDa and 
32-35 kDa have been described for the protein compo- 
nents of these channels (Glossmann et al. [28]5; Galizzi 
et al. [29]; Glossmann et al. [30]). Their relationship to 
the corresponding sulfonylurea-labeled polypeptides 
has to be elucidated. 
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